Global Biopharma Industry Pulling Out All the Stops to Address Coronavirus

Unprecedented level of collaboration aims to further accelerate the development of new diagnostics, vaccines and treatments for patients.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the world’s leading biopharmaceutical companies, has mobilized on an unprecedented scale to respond to the COVID-19 pandemic. The biopharmaceutical industry commits to accelerate its effort to use its skills, technology and resources to bring safe, effective diagnostics, treatments and vaccines to patients around the world. David Ricks, Chairman and CEO of Eli Lilly and Co. and IFPMA President,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters